JP5164224B2 - ペーシング用のパターニングされた導電性ポリマー電極 - Google Patents
ペーシング用のパターニングされた導電性ポリマー電極 Download PDFInfo
- Publication number
- JP5164224B2 JP5164224B2 JP2009529284A JP2009529284A JP5164224B2 JP 5164224 B2 JP5164224 B2 JP 5164224B2 JP 2009529284 A JP2009529284 A JP 2009529284A JP 2009529284 A JP2009529284 A JP 2009529284A JP 5164224 B2 JP5164224 B2 JP 5164224B2
- Authority
- JP
- Japan
- Prior art keywords
- conductive polymer
- coating
- electrode
- conductive
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001940 conductive polymer Polymers 0.000 title claims description 48
- 238000000576 coating method Methods 0.000 claims description 68
- 239000011248 coating agent Substances 0.000 claims description 67
- 229920000642 polymer Polymers 0.000 claims description 65
- 238000000034 method Methods 0.000 claims description 32
- 229910052751 metal Inorganic materials 0.000 claims description 25
- 239000002184 metal Substances 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 17
- 239000004020 conductor Substances 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 14
- 229920000128 polypyrrole Polymers 0.000 claims description 13
- 230000000747 cardiac effect Effects 0.000 claims description 12
- 238000000151 deposition Methods 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 239000002202 Polyethylene glycol Substances 0.000 claims description 9
- 238000004070 electrodeposition Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000005240 physical vapour deposition Methods 0.000 claims description 4
- 238000004544 sputter deposition Methods 0.000 claims description 4
- 238000003618 dip coating Methods 0.000 claims description 3
- 238000001548 drop coating Methods 0.000 claims description 3
- 238000001523 electrospinning Methods 0.000 claims description 3
- 238000005553 drilling Methods 0.000 claims description 2
- 229920000554 ionomer Polymers 0.000 claims description 2
- 238000005530 etching Methods 0.000 claims 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 claims 1
- 229910052744 lithium Inorganic materials 0.000 claims 1
- 229940049964 oleate Drugs 0.000 claims 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims 1
- 125000005498 phthalate group Chemical class 0.000 claims 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 24
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 24
- 238000000059 patterning Methods 0.000 description 12
- 239000000463 material Substances 0.000 description 9
- 239000011253 protective coating Substances 0.000 description 9
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 6
- 229910000457 iridium oxide Inorganic materials 0.000 description 6
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 6
- 229960002796 polystyrene sulfonate Drugs 0.000 description 6
- 239000011970 polystyrene sulfonate Substances 0.000 description 6
- 229910052719 titanium Inorganic materials 0.000 description 6
- 239000010936 titanium Substances 0.000 description 6
- 206010003119 arrhythmia Diseases 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 230000006793 arrhythmia Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000002019 doping agent Substances 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 238000010329 laser etching Methods 0.000 description 4
- 229920000123 polythiophene Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- 229910052715 tantalum Inorganic materials 0.000 description 4
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 208000033988 Device pacing issue Diseases 0.000 description 3
- 229920000557 Nafion® Polymers 0.000 description 3
- 239000003124 biologic agent Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000002484 cyclic voltammetry Methods 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- -1 PEDOT Polymers 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 2
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 229920006237 degradable polymer Polymers 0.000 description 2
- 229960003657 dexamethasone acetate Drugs 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000011810 insulating material Substances 0.000 description 2
- 238000007735 ion beam assisted deposition Methods 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 150000002736 metal compounds Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000006794 tachycardia Effects 0.000 description 2
- MZLGASXMSKOWSE-UHFFFAOYSA-N tantalum nitride Chemical compound [Ta]#N MZLGASXMSKOWSE-UHFFFAOYSA-N 0.000 description 2
- 229910001936 tantalum oxide Inorganic materials 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- MTPVUVINMAGMJL-UHFFFAOYSA-N trimethyl(1,1,2,2,2-pentafluoroethyl)silane Chemical compound C[Si](C)(C)C(F)(F)C(F)(F)F MTPVUVINMAGMJL-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GKWLILHTTGWKLQ-UHFFFAOYSA-N 2,3-dihydrothieno[3,4-b][1,4]dioxine Chemical compound O1CCOC2=CSC=C21 GKWLILHTTGWKLQ-UHFFFAOYSA-N 0.000 description 1
- HWMQCIZYXLAJKM-UHFFFAOYSA-N 3-(2-ethylhexyl)thiophene Chemical compound CCCCC(CC)CC=1C=CSC=1 HWMQCIZYXLAJKM-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000002228 NASICON Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002095 anti-migrative effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000002769 anti-restenotic effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009876 antimalignant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000005388 borosilicate glass Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 238000013194 cardioversion Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005234 chemical deposition Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000011231 conductive filler Substances 0.000 description 1
- 229940072645 coumadin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001746 electroactive polymer Polymers 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000005468 ion implantation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-M naphthalene-1-sulfonate Chemical compound C1=CC=C2C(S(=O)(=O)[O-])=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-M 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920000417 polynaphthalene Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000012255 powdered metal Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 229960002930 sirolimus Drugs 0.000 description 1
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
- A61N1/0565—Electrode heads
- A61N1/0568—Electrode heads with drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/533,644 | 2006-09-20 | ||
| US11/533,644 US8311606B2 (en) | 2006-09-20 | 2006-09-20 | Conductive polymer patterned electrode for pacing |
| PCT/US2007/073997 WO2008036460A1 (en) | 2006-09-20 | 2007-07-20 | Conductive polymer patterned electrode for pacing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010504159A JP2010504159A (ja) | 2010-02-12 |
| JP2010504159A5 JP2010504159A5 (enExample) | 2010-09-09 |
| JP5164224B2 true JP5164224B2 (ja) | 2013-03-21 |
Family
ID=38917703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009529284A Expired - Fee Related JP5164224B2 (ja) | 2006-09-20 | 2007-07-20 | ペーシング用のパターニングされた導電性ポリマー電極 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8311606B2 (enExample) |
| EP (1) | EP2069002A1 (enExample) |
| JP (1) | JP5164224B2 (enExample) |
| WO (1) | WO2008036460A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009051945A1 (en) * | 2007-10-15 | 2009-04-23 | Cardiac Pacemakers, Inc. | Conductive composite electrode material |
| WO2009055186A2 (en) | 2007-10-19 | 2009-04-30 | Cardiac Pacemakers, Inc. | Fibrous electrode material |
| DE102008028410B4 (de) * | 2008-06-17 | 2011-04-07 | W.C. Heraeus Gmbh | Selektive Parylene-Beschichtung für Herzschrittmacherelektroden |
| WO2010059305A1 (en) * | 2008-11-20 | 2010-05-27 | Cardiac Pacemakers, Inc. | Cell-repelling electrode having a structured surface |
| US11331424B2 (en) | 2009-01-26 | 2022-05-17 | Incube Labs, Llc | Apparatus, systems and methods for delivery of medication to the brain to treat neurological conditions |
| US8644927B2 (en) | 2009-04-21 | 2014-02-04 | Incube Labs, Llc | Apparatus and method for the detection and treatment of atrial fibrillation |
| EP2505229A3 (de) * | 2011-03-30 | 2013-09-04 | BIOTRONIK SE & Co. KG | Implantierbares Gerät |
| JP2012235875A (ja) * | 2011-05-11 | 2012-12-06 | Olympus Corp | 電気刺激デバイス |
| AU2012295332B2 (en) | 2011-08-12 | 2014-12-04 | Cardiac Pacemakers, Inc. | Method for coating devices using electrospinning and melt blowing |
| JP6200895B2 (ja) | 2011-11-21 | 2017-09-20 | インキューブ ラブズ, エルエルシー | 心筋薬剤送達装置および方法 |
| US20150025608A1 (en) * | 2013-07-22 | 2015-01-22 | Cardiac Pacemakers, Inc. | Lubricious, biocompatible hydrophilic thermoset coating using interpenetrating hydrogel networks |
| AU2016297810B2 (en) | 2015-07-25 | 2018-05-17 | Cardiac Pacemakers, Inc. | Medical electrical lead with biostable PVDF-based materials |
| US10092764B2 (en) | 2015-08-20 | 2018-10-09 | Cardiac Pacemakers, Inc. | Implantable medical device with modified surface texture |
| CA2998525C (en) | 2015-10-01 | 2021-06-15 | T&W Engineering A/S | Ear canal plug for detecting bio-electrical signals |
| JP6010203B2 (ja) * | 2015-10-05 | 2016-10-19 | 日本電信電話株式会社 | 導電体、生体電極、及び生体信号測定装置 |
| US11602281B2 (en) | 2015-11-02 | 2023-03-14 | North Carolina State University | Injectable sensors and methods of use |
| US10729901B2 (en) | 2016-11-14 | 2020-08-04 | Verily Life Sciences Llc | Implantable electrodes comprising mechanically constrained biocompatible hydrogels with conductive passthrough |
| WO2018089975A1 (en) | 2016-11-14 | 2018-05-17 | Verily Life Sciences Llc | Implantable electrodes comprising mechanically anchored biocompatible hydrogels |
| EP3562524B1 (en) | 2016-12-27 | 2021-04-07 | Boston Scientific Scimed Inc. | Degradable scaffolding for electrospinning on a medical device |
| WO2019040644A1 (en) * | 2017-08-22 | 2019-02-28 | University Of Houston System | CONDUCTIVE POLYMERIC MICRORLECIPIENTS FOR ORGANIC BIOELECTRONICS AND DRUG DELIVERY |
| EP3961077B1 (de) * | 2020-08-27 | 2023-09-27 | TI Automotive (Heidelberg) GmbH | Verfahren zur behandlung einer rohrleitung, rohrleitung und rohranschlusseinrichtung |
| CN112885953B (zh) * | 2021-01-11 | 2023-01-13 | 天津工业大学 | 一种肖特基直流发电机及其制备方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4226247A (en) * | 1978-08-21 | 1980-10-07 | Hauser Laboratories | Biological electrode |
| US4524087A (en) * | 1980-01-23 | 1985-06-18 | Minnesota Mining And Manufacturing Company | Conductive adhesive and biomedical electrode |
| US4542752A (en) * | 1983-04-22 | 1985-09-24 | Cordis Corporation | Implantable device having porous surface with carbon coating |
| US4844099A (en) * | 1986-11-24 | 1989-07-04 | Telectronics, N.V. | Porous pacemaker electrode tip using a porous substrate |
| US5078138A (en) * | 1988-09-22 | 1992-01-07 | Minnesota Mining And Manufacturing Company | Biomedical electrode construction having a non-woven material |
| US4968390A (en) * | 1988-11-03 | 1990-11-06 | Board Of Regents, The University Of Texas System | High resolution deposition and etching in polymer films |
| US5524338A (en) * | 1991-10-22 | 1996-06-11 | Pi Medical Corporation | Method of making implantable microelectrode |
| AU667199B2 (en) * | 1991-11-08 | 1996-03-14 | Physiometrix, Inc. | EEG headpiece with disposable electrodes and apparatus and system and method for use therewith |
| JPH0815486B2 (ja) * | 1992-03-17 | 1996-02-21 | 日本光電工業株式会社 | 生体用電極の製造方法 |
| US5529579A (en) * | 1994-05-12 | 1996-06-25 | Intermedics, Inc. | Implantable automatic difibrillator with low threshold |
| US6501994B1 (en) * | 1997-12-24 | 2002-12-31 | Cardiac Pacemakers, Inc. | High impedance electrode tip |
| US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
| US6295474B1 (en) * | 1998-03-13 | 2001-09-25 | Intermedics Inc. | Defibrillator housing with conductive polymer coating |
| US6757556B2 (en) * | 1998-05-26 | 2004-06-29 | Ineedmd. Com | Electrode sensor |
| US6240320B1 (en) | 1998-06-05 | 2001-05-29 | Intermedics Inc. | Cardiac lead with zone insulated electrodes |
| US6546292B1 (en) | 1998-11-04 | 2003-04-08 | Gore Enterprise Holdings, Inc. | High impedance, low polarization cardiac electrode |
| EP1079397A1 (en) | 1999-08-23 | 2001-02-28 | Agfa-Gevaert N.V. | Method of making an electroconductive pattern on a support |
| US6444400B1 (en) * | 1999-08-23 | 2002-09-03 | Agfa-Gevaert | Method of making an electroconductive pattern on a support |
| US6799076B2 (en) * | 1999-12-07 | 2004-09-28 | Greatbatch-Hittman, Inc. | Coated electrode and method of making a coated electrode |
| WO2002045795A2 (en) * | 2000-12-07 | 2002-06-13 | Medtronic, Inc. | Directional brain stimulation and recording leads |
| US7596415B2 (en) | 2002-12-06 | 2009-09-29 | Medtronic, Inc. | Medical devices incorporating carbon nanotube material and methods of fabricating same |
| US20060111626A1 (en) * | 2003-03-27 | 2006-05-25 | Cvrx, Inc. | Electrode structures having anti-inflammatory properties and methods of use |
| DE10327500B4 (de) | 2003-06-17 | 2007-03-15 | W.C. Heraeus Gmbh | Verfahren zur Herstellung von Elektrodenstrukturen sowie Elektrodenstruktur und deren Verwendung |
| US7463917B2 (en) * | 2004-04-28 | 2008-12-09 | Medtronic, Inc. | Electrodes for sustained delivery of energy |
| EP1766672A2 (en) * | 2004-05-14 | 2007-03-28 | California Institute of Technology | Parylene-based flexible multi-electrode arrays for neuronal stimulation and recording and methods for manufacturing the same |
| US7496408B2 (en) | 2004-12-03 | 2009-02-24 | Medtronic, Inc. | Electrodes array for a pacemaker |
-
2006
- 2006-09-20 US US11/533,644 patent/US8311606B2/en not_active Expired - Fee Related
-
2007
- 2007-07-20 JP JP2009529284A patent/JP5164224B2/ja not_active Expired - Fee Related
- 2007-07-20 WO PCT/US2007/073997 patent/WO2008036460A1/en not_active Ceased
- 2007-07-20 EP EP07813172A patent/EP2069002A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008036460A1 (en) | 2008-03-27 |
| US20080071338A1 (en) | 2008-03-20 |
| EP2069002A1 (en) | 2009-06-17 |
| US8311606B2 (en) | 2012-11-13 |
| JP2010504159A (ja) | 2010-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5164224B2 (ja) | ペーシング用のパターニングされた導電性ポリマー電極 | |
| JP5009974B2 (ja) | 心臓電極を備えた心臓リード及び心臓電極の被覆方法 | |
| EP2389976B1 (en) | Lead with fibrous matrix coating | |
| US6295474B1 (en) | Defibrillator housing with conductive polymer coating | |
| US5324324A (en) | Coated implantable stimulation electrode and lead | |
| AU637353B2 (en) | Patch electrodes for use with defibrillators | |
| Mond et al. | The electrode‐tissue interface: the revolutionary role of steroid‐elution | |
| JP2838480B2 (ja) | 人体刺激/感知リード、同電極及びこの電極の製造方法 | |
| JP4597133B2 (ja) | 薬物溶離電極を備えた装置及びその装置の製造方法 | |
| US5154182A (en) | Drug or steroid releasing patch electrode for an implantable arrhythmia treatment system | |
| US20070051531A1 (en) | Drug eluting coatings for a medical lead and method therefor | |
| EP1832310A2 (en) | Medical lead with tissue-protecting tip structure | |
| EP0791372A1 (en) | Medical electrical lead | |
| JP2010540105A (ja) | 繊維性電極材料 | |
| JP2009540950A (ja) | タッキーリードのショッキングコイルのコーティング | |
| EP1885436A2 (en) | Coated lead fixation electrode | |
| EP3906964A1 (en) | Recessed electrodes for flexible substrates | |
| JP2007526791A (ja) | 新規な双極ペーシング対を有する医療システム | |
| EP1568394A1 (en) | Coated electrode |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100720 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100720 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120726 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121030 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20121126 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20121214 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20151228 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5164224 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20121214 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |